Institutional investors purchased a net $1.2 million shares of SUPN during the quarter ended September 2014 and now own 50.44% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DISCOVERY GROUP I LLC Bought 389.9 Thousand shares of Supernus Pharmaceuticals ...
BRUCE & CO., INC. Bought 300.0 Thousand shares of Supernus Pharmaceuticals ...